Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 9Lung Neoplasms 3Uterine Cervical Neoplasms 2Neoplasms 2Motor Activity 2Colorectal Neoplasms 2Anxiety Disorders 2Sarcopenia 1Resectable Lung Non-Small Cell Carcinoma 1Psychological Well-Being 1Prostatic Neoplasms 1Postoperative Complications 1Parasomnias 1Panic Disorder 1Pancreatic Neoplasms 1Liver Neoplasms 1Fatigue 1Emotional Regulation 1Depression 1Colonic Neoplasms 1Caregivers With a Child Followed up With a Cancer Diagnosis 1Bile Duct Neoplasms 1

Interventions

Sorafenib 61Bevacizumab 42Oxaliplatin 24Doxorubicin 22Radiosurgery 20Gemcitabine 20Fluorouracil 20Nivolumab 19durvalumab 18Radiofrequency Ablation 18pembrolizumab 17Capecitabine 17lenvatinib 16Cisplatin 16atezolizumab 13Leucovorin 13Radiotherapy 11tremelimumab 10Cyclophosphamide 10Carboplatin 10Irinotecan 9Ipilimumab 9Drug Therapy 9Everolimus 8Cryosurgery 8toripalimab 7fludarabine 7Sunitinib 7Chemotherapy, Adjuvant 7Melphalan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Liver Neoplasms × Relaxation Therapy × Clear all
NCT03475966 2020-12-08

Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase NA Unknown
60 enrolled
Gastrointestinal

Bile Duct Neoplasms, Liver Neoplasms, Motor Activity, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡